Generic Estrace is used for treating conditions due to menopause (eg, hot flashes; vaginal itching, burning, or dryness), treating vulval or vaginal atrophy, and preventing osteoporosis (brittle bones). It is also used for estrogen replacement therapy after failure of the ovaries and to relieve the symptoms of breast cancer.
Generic Evista is used for treating and preventing osteoporosis (bone thinning) in women who are past menopause. It is also used to reduce the risk of invasive breast cancer in certain women who are past menopause.
Generic Premarin is used for treating certain symptoms of menopause (eg, hot flashes, vaginal dryness or itching). It is used to prevent osteoporosis (weak bones) after menopause in certain patients. It is also used in certain patients to treat low estrogen levels, prostate cancer or breast cancer.
Drug Delivery Microchip Implanted in Patients, Passes Human Trial - Singularity Hub
Singularity HubDrug Delivery Microchip Implanted in Patients, Passes Human TrialSingularity HubA microchip was implanted in 8 women and delivered a drug to treat osteoporosis once a day for 20 days.
Chip could end daily jabs for osteoporosis - Daily Mail
ABC News (blog)Chip could end daily jabs for osteoporosisDaily MailBy Fiona Macrae Science Correspondent Scientists have invented an electronic chip that could put an end to painful daily injections for osteoporosis sufferers.
Exercise in early twenties may lower risk of osteoporosis, study finds - Ortho SuperSite
Exercise in early twenties may lower risk of osteoporosis, study findsOrtho SuperSiteAccording to the abstract, 1068 young men enrolled in the Gothenburg Osteoporosis and Obesity Determinants study were invited to participate in the study, with 833 men with an average age of 24.
Nano-enabled nasal spray for osteoporosis - Medical Xpress
HealthJockey.
Heart failure linked to thinner bones and fractures - Ortho SuperSite
Heart failure linked to thinner bones and fracturesOrtho SuperSiteHeart failure is associated with a 30% increase in major fractures and could identify a high-risk population that may benefit from increased osteoporosis screening and treatment, according to a study in the Journal of Clinical Endocrinology .
